لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Tsuchikama K; Texas Therapeutics Institute, The Brown Foundation Institute of Molecular Medicine, The University of Texas Health Science Center at Houston, Houston, TX, USA. kyoji.tsuchikama@uth.tmc.edu., Anami Y; Texas Therapeutics Institute, The Brown Foundation Institute of Molecular Medicine, The University of Texas Health Science Center at Houston, Houston, TX, USA., Ha SYY; Texas Therapeutics Institute, The Brown Foundation Institute of Molecular Medicine, The University of Texas Health Science Center at Houston, Houston, TX, USA., Yamazaki CM; Texas Therapeutics Institute, The Brown Foundation Institute of Molecular Medicine, The University of Texas Health Science Center at Houston, Houston, TX, USA.

المصدر: Nature reviews. Clinical oncology [Nat Rev Clin Oncol] 2024 Mar; Vol. 21 (3), pp. 203-223. Date of Electronic Publication: 2024 Jan 08.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101500077 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1759-4782 (Electronic) Linking ISSN: 17594774 NLM ISO Abbreviation: Nat Rev Clin Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Immunoconjugates*/chemistry , Antineoplastic Agents*/therapeutic use , Neoplasms*, Humans ; Antibodies, Monoclonal/adverse effects ; Pharmaceutical Preparations

المؤلفون: Ha SYY; Texas Therapeutics Institute, The Brown Foundation Institute of Molecular Medicine, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, Texas., Anami Y; Texas Therapeutics Institute, The Brown Foundation Institute of Molecular Medicine, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, Texas., Yamazaki CM; Texas Therapeutics Institute, The Brown Foundation Institute of Molecular Medicine, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, Texas., Xiong W; Texas Therapeutics Institute, The Brown Foundation Institute of Molecular Medicine, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, Texas., Haase CM; Department of Pediatric Surgery, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, Texas., Olson SD; Department of Pediatric Surgery, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, Texas., Lee J; Section of Translational Breast Cancer Research, Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Ueno NT; Section of Translational Breast Cancer Research, Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Zhang N; Texas Therapeutics Institute, The Brown Foundation Institute of Molecular Medicine, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, Texas., An Z; Texas Therapeutics Institute, The Brown Foundation Institute of Molecular Medicine, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, Texas., Tsuchikama K; Texas Therapeutics Institute, The Brown Foundation Institute of Molecular Medicine, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, Texas.

المصدر: Molecular cancer therapeutics [Mol Cancer Ther] 2022 Sep 06; Vol. 21 (9), pp. 1449-1461.

نوع المنشور: Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: American Association for Cancer Research, Inc Country of Publication: United States NLM ID: 101132535 Publication Model: Print Cited Medium: Internet ISSN: 1538-8514 (Electronic) Linking ISSN: 15357163 NLM ISO Abbreviation: Mol Cancer Ther Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Agents*/pharmacology , Antineoplastic Agents*/therapeutic use , Immunoconjugates*/metabolism , Immunoconjugates*/pharmacology, Ado-Trastuzumab Emtansine ; Animals ; Cell Line, Tumor ; Citrulline ; Humans ; Mice ; Peptide Hydrolases ; Therapeutic Index

المؤلفون: Anami Y; Texas Therapeutics Institute, The Brown Foundation Institute of Molecular Medicine, McGovern Medical School, The University of Texas Health Center at Houston Houston Texas 77054 USA Kyoji.Tsuchikama@uth.tmc.edu Zhiqiang.An@uth.tmc.edu Ningyan.Zhang@uth.tmc.edu Chisato.Tsuchikama@uth.tmc.edu Aiko.Yamaguchi@uth.tmc.edu., Xiong W; Texas Therapeutics Institute, The Brown Foundation Institute of Molecular Medicine, McGovern Medical School, The University of Texas Health Center at Houston Houston Texas 77054 USA Kyoji.Tsuchikama@uth.tmc.edu Zhiqiang.An@uth.tmc.edu Ningyan.Zhang@uth.tmc.edu Chisato.Tsuchikama@uth.tmc.edu Aiko.Yamaguchi@uth.tmc.edu., Yamaguchi A; Texas Therapeutics Institute, The Brown Foundation Institute of Molecular Medicine, McGovern Medical School, The University of Texas Health Center at Houston Houston Texas 77054 USA Kyoji.Tsuchikama@uth.tmc.edu Zhiqiang.An@uth.tmc.edu Ningyan.Zhang@uth.tmc.edu Chisato.Tsuchikama@uth.tmc.edu Aiko.Yamaguchi@uth.tmc.edu., Yamazaki CM; Texas Therapeutics Institute, The Brown Foundation Institute of Molecular Medicine, McGovern Medical School, The University of Texas Health Center at Houston Houston Texas 77054 USA Kyoji.Tsuchikama@uth.tmc.edu Zhiqiang.An@uth.tmc.edu Ningyan.Zhang@uth.tmc.edu Chisato.Tsuchikama@uth.tmc.edu Aiko.Yamaguchi@uth.tmc.edu., Zhang N; Texas Therapeutics Institute, The Brown Foundation Institute of Molecular Medicine, McGovern Medical School, The University of Texas Health Center at Houston Houston Texas 77054 USA Kyoji.Tsuchikama@uth.tmc.edu Zhiqiang.An@uth.tmc.edu Ningyan.Zhang@uth.tmc.edu Chisato.Tsuchikama@uth.tmc.edu Aiko.Yamaguchi@uth.tmc.edu., An Z; Texas Therapeutics Institute, The Brown Foundation Institute of Molecular Medicine, McGovern Medical School, The University of Texas Health Center at Houston Houston Texas 77054 USA Kyoji.Tsuchikama@uth.tmc.edu Zhiqiang.An@uth.tmc.edu Ningyan.Zhang@uth.tmc.edu Chisato.Tsuchikama@uth.tmc.edu Aiko.Yamaguchi@uth.tmc.edu., Tsuchikama K; Texas Therapeutics Institute, The Brown Foundation Institute of Molecular Medicine, McGovern Medical School, The University of Texas Health Center at Houston Houston Texas 77054 USA Kyoji.Tsuchikama@uth.tmc.edu Zhiqiang.An@uth.tmc.edu Ningyan.Zhang@uth.tmc.edu Chisato.Tsuchikama@uth.tmc.edu Aiko.Yamaguchi@uth.tmc.edu.

المصدر: RSC advances [RSC Adv] 2022 Jan 26; Vol. 12 (6), pp. 3359-3364. Date of Electronic Publication: 2022 Jan 26 (Print Publication: 2022).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Royal Society of Chemistry Country of Publication: England NLM ID: 101581657 Publication Model: eCollection Cited Medium: Internet ISSN: 2046-2069 (Electronic) Linking ISSN: 20462069 NLM ISO Abbreviation: RSC Adv Subsets: PubMed not MEDLINE

المؤلفون: Yamazaki CM; Texas Therapeutics Institute, The Brown Foundation Institute of Molecular Medicine, The University of Texas Health Science Center at Houston, Houston, TX, USA., Yamaguchi A; Texas Therapeutics Institute, The Brown Foundation Institute of Molecular Medicine, The University of Texas Health Science Center at Houston, Houston, TX, USA., Anami Y; Texas Therapeutics Institute, The Brown Foundation Institute of Molecular Medicine, The University of Texas Health Science Center at Houston, Houston, TX, USA., Xiong W; Texas Therapeutics Institute, The Brown Foundation Institute of Molecular Medicine, The University of Texas Health Science Center at Houston, Houston, TX, USA., Otani Y; Department of Neurosurgery, The University of Texas Health Science Center at Houston, Houston, TX, USA., Lee J; Section of Translational Breast Cancer Research, Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Ueno NT; Section of Translational Breast Cancer Research, Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Zhang N; Texas Therapeutics Institute, The Brown Foundation Institute of Molecular Medicine, The University of Texas Health Science Center at Houston, Houston, TX, USA., An Z; Texas Therapeutics Institute, The Brown Foundation Institute of Molecular Medicine, The University of Texas Health Science Center at Houston, Houston, TX, USA., Tsuchikama K; Texas Therapeutics Institute, The Brown Foundation Institute of Molecular Medicine, The University of Texas Health Science Center at Houston, Houston, TX, USA. Kyoji.Tsuchikama@uth.tmc.edu.

المصدر: Nature communications [Nat Commun] 2021 Jun 10; Vol. 12 (1), pp. 3528. Date of Electronic Publication: 2021 Jun 10.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.

بيانات الدورية: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Combined Chemotherapy Protocols/*pharmacology , Breast Neoplasms/*drug therapy , Immunoconjugates/*pharmacology , Receptor, ErbB-2/*immunology, Animals ; Antineoplastic Agents/pharmacology ; Breast Neoplasms/complications ; Cell Line, Tumor ; Female ; Humans ; Immunoconjugates/pharmacokinetics ; Immunoconjugates/therapeutic use ; Immunoconjugates/toxicity ; Immunohistochemistry ; Inflammation/complications ; Mice ; Oligopeptides/pharmacology ; Oligopeptides/therapeutic use ; Receptor, ErbB-2/metabolism ; Trastuzumab/pharmacology ; Trastuzumab/therapeutic use ; Xenograft Model Antitumor Assays

المؤلفون: Anami Y; Texas Therapeutics Institute, The Brown Foundation Institute of Molecular Medicine, The University of Texas Health Science Center at Houston, Houston, Texas., Deng M; Department of Physiology, The University of Texas Southwestern Medical Center, Dallas, Texas., Gui X; Texas Therapeutics Institute, The Brown Foundation Institute of Molecular Medicine, The University of Texas Health Science Center at Houston, Houston, Texas., Yamaguchi A; Texas Therapeutics Institute, The Brown Foundation Institute of Molecular Medicine, The University of Texas Health Science Center at Houston, Houston, Texas., Yamazaki CM; Texas Therapeutics Institute, The Brown Foundation Institute of Molecular Medicine, The University of Texas Health Science Center at Houston, Houston, Texas., Zhang N; Texas Therapeutics Institute, The Brown Foundation Institute of Molecular Medicine, The University of Texas Health Science Center at Houston, Houston, Texas., Zhang CC; Department of Physiology, The University of Texas Southwestern Medical Center, Dallas, Texas. Kyoji.Tsuchikama@uth.tmc.edu Alec.Zhang@UTSouthwestern.edu Zhiqiang.An@uth.tmc.edu., An Z; Texas Therapeutics Institute, The Brown Foundation Institute of Molecular Medicine, The University of Texas Health Science Center at Houston, Houston, Texas. Kyoji.Tsuchikama@uth.tmc.edu Alec.Zhang@UTSouthwestern.edu Zhiqiang.An@uth.tmc.edu., Tsuchikama K; Texas Therapeutics Institute, The Brown Foundation Institute of Molecular Medicine, The University of Texas Health Science Center at Houston, Houston, Texas. Kyoji.Tsuchikama@uth.tmc.edu Alec.Zhang@UTSouthwestern.edu Zhiqiang.An@uth.tmc.edu.

المصدر: Molecular cancer therapeutics [Mol Cancer Ther] 2020 Nov; Vol. 19 (11), pp. 2330-2339. Date of Electronic Publication: 2020 Sep 02.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.

بيانات الدورية: Publisher: American Association for Cancer Research, Inc Country of Publication: United States NLM ID: 101132535 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1538-8514 (Electronic) Linking ISSN: 15357163 NLM ISO Abbreviation: Mol Cancer Ther Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Agents, Immunological/*pharmacology , Immunoconjugates/*pharmacology , Membrane Glycoproteins/*antagonists & inhibitors , Receptors, Immunologic/*antagonists & inhibitors, Animals ; Antineoplastic Agents, Immunological/chemistry ; Cell Line, Tumor ; Disease Models, Animal ; Drug Stability ; Humans ; Hydrophobic and Hydrophilic Interactions ; Immunoconjugates/chemistry ; Leukemia, Myeloid, Acute/drug therapy ; Leukemia, Myeloid, Acute/etiology ; Leukemia, Myeloid, Acute/mortality ; Leukemia, Myeloid, Acute/pathology ; Mice ; Protein Binding ; Recombinant Fusion Proteins/chemistry ; Recombinant Fusion Proteins/pharmacology ; Treatment Outcome ; Xenograft Model Antitumor Assays

المؤلفون: Anami Y; Texas Therapeutics Institute, The Brown Foundation Institute of Molecular Medicine, The University of Texas Health Science Center at Houston, 1881 East Road, Houston, TX, 77054, USA., Yamazaki CM; Texas Therapeutics Institute, The Brown Foundation Institute of Molecular Medicine, The University of Texas Health Science Center at Houston, 1881 East Road, Houston, TX, 77054, USA., Xiong W; Texas Therapeutics Institute, The Brown Foundation Institute of Molecular Medicine, The University of Texas Health Science Center at Houston, 1881 East Road, Houston, TX, 77054, USA., Gui X; Texas Therapeutics Institute, The Brown Foundation Institute of Molecular Medicine, The University of Texas Health Science Center at Houston, 1881 East Road, Houston, TX, 77054, USA., Zhang N; Texas Therapeutics Institute, The Brown Foundation Institute of Molecular Medicine, The University of Texas Health Science Center at Houston, 1881 East Road, Houston, TX, 77054, USA., An Z; Texas Therapeutics Institute, The Brown Foundation Institute of Molecular Medicine, The University of Texas Health Science Center at Houston, 1881 East Road, Houston, TX, 77054, USA., Tsuchikama K; Texas Therapeutics Institute, The Brown Foundation Institute of Molecular Medicine, The University of Texas Health Science Center at Houston, 1881 East Road, Houston, TX, 77054, USA. Kyoji.Tsuchikama@uth.tmc.edu.

المصدر: Nature communications [Nat Commun] 2018 Jun 28; Vol. 9 (1), pp. 2512. Date of Electronic Publication: 2018 Jun 28.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.

بيانات الدورية: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

مواضيع طبية MeSH: Antibodies, Monoclonal/*pharmacology , Antineoplastic Agents/*pharmacology , Breast Neoplasms/*drug therapy , Glutamic Acid/*chemistry , Immunoconjugates/*pharmacology , Oligopeptides/*chemistry, Animals ; Antibodies, Monoclonal/chemistry ; Antibodies, Monoclonal/pharmacokinetics ; Antineoplastic Agents/chemistry ; Antineoplastic Agents/pharmacokinetics ; Breast Neoplasms/genetics ; Breast Neoplasms/mortality ; Breast Neoplasms/pathology ; Carboxylic Ester Hydrolases/blood ; Cell Line, Tumor ; Citrulline/chemistry ; Drug Design ; Drug Stability ; Female ; Gene Expression ; Humans ; Hydrolysis ; Immunoconjugates/chemistry ; Immunoconjugates/pharmacokinetics ; Mice ; Mice, Inbred BALB C ; Mice, Nude ; Receptor, ErbB-2/antagonists & inhibitors ; Receptor, ErbB-2/genetics ; Receptor, ErbB-2/metabolism ; Survival Analysis ; Valine/chemistry ; Xenograft Model Antitumor Assays

المؤلفون: Sugahara KN; Cancer Research Center, Sanford-Burnham Medical Research Institute, 10901 North Torrey Pines Road, La Jolla, CA 92037, USA; Department of Surgery, Columbia University College of Physicians and Surgeons, Herbert Irving Comprehensive Cancer Center, 1130St Nicholas Avenue, New York, NY 10032, USA. Electronic address: sugahara@sanfordburnham.org., Scodeller P; Cancer Research Center, Sanford-Burnham Medical Research Institute, 10901 North Torrey Pines Road, La Jolla, CA 92037, USA. Electronic address: pscodeller@sanfordburnham.org., Braun GB; Cancer Research Center, Sanford-Burnham Medical Research Institute, 10901 North Torrey Pines Road, La Jolla, CA 92037, USA; Center of Nanomedicine and Department of Cell, Molecular and Developmental Biology, 2203 Life Sciences Building, MCDB, University of California, Santa Barbara, CA 93106-9625, USA. Electronic address: gbraun@sanfordburnham.org., de Mendoza TH; Cancer Research Center, Sanford-Burnham Medical Research Institute, 10901 North Torrey Pines Road, La Jolla, CA 92037, USA. Electronic address: thurtado@sanfordburnham.org., Yamazaki CM; Department of Surgery, Columbia University College of Physicians and Surgeons, Herbert Irving Comprehensive Cancer Center, 1130St Nicholas Avenue, New York, NY 10032, USA. Electronic address: ct2621@cumc.columbia.edu., Kluger MD; Department of Surgery, Columbia University College of Physicians and Surgeons, Herbert Irving Comprehensive Cancer Center, 1130St Nicholas Avenue, New York, NY 10032, USA. Electronic address: mk2462@cumc.columbia.edu., Kitayama J; Department of Surgical Oncology, The University of Tokyo, Bunkyo-ku, Tokyo, Japan. Electronic address: kitayama-1SU@h.u-tokyo.ac.jp., Alvarez E; Department of Reproductive Medicine, Division of Gynecologic Oncology, Moores Cancer Center, 3855 Health Sciences Drive, La Jolla, CA 92093-0987, USA. Electronic address: Edwin.alvarez@ucdmc.ucdavis.edu., Howell SB; Department of Medicine, Moores Cancer Center, 3855 Health Sciences Drive, La Jolla, CA 92093-0819, USA. Electronic address: showell@ucsd.edu., Teesalu T; Cancer Research Center, Sanford-Burnham Medical Research Institute, 10901 North Torrey Pines Road, La Jolla, CA 92037, USA; Center of Nanomedicine and Department of Cell, Molecular and Developmental Biology, 2203 Life Sciences Building, MCDB, University of California, Santa Barbara, CA 93106-9625, USA; Institute of Biomedicine and Translational Medicine, Centre of Excellence for Translational Medicine, University of Tartu, Ravila 14b, Tartu 50411, Estonia. Electronic address: tteesalu@sanfordburnham.org., Ruoslahti E; Cancer Research Center, Sanford-Burnham Medical Research Institute, 10901 North Torrey Pines Road, La Jolla, CA 92037, USA; Center of Nanomedicine and Department of Cell, Molecular and Developmental Biology, 2203 Life Sciences Building, MCDB, University of California, Santa Barbara, CA 93106-9625, USA. Electronic address: ruoslahti@sanfordburnham.org., Lowy AM; Department of Surgery, Division of Surgical Oncology, Moores Cancer Center, 3855 Health Sciences Drive, La Jolla, CA 92093-0987, USA. Electronic address: alowy@ucsd.edu.

المصدر: Journal of controlled release : official journal of the Controlled Release Society [J Control Release] 2015 Aug 28; Vol. 212, pp. 59-69. Date of Electronic Publication: 2015 Jun 11.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Science Publishers Country of Publication: Netherlands NLM ID: 8607908 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-4995 (Electronic) Linking ISSN: 01683659 NLM ISO Abbreviation: J Control Release Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Combined Chemotherapy Protocols/*administration & dosage , Carcinoma/*drug therapy , Cell-Penetrating Peptides/*administration & dosage , Doxorubicin/*administration & dosage , Oligopeptides/*administration & dosage , Peritoneal Neoplasms/*drug therapy, Animals ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Cell Line, Tumor ; Cell-Penetrating Peptides/therapeutic use ; Doxorubicin/therapeutic use ; Humans ; Mice, Nude ; Oligopeptides/therapeutic use ; Regional Blood Flow

المؤلفون: Yasui H; Department of Analytical and Bioinorganic Chemistry, Division of Analytical and Physical Chemistry, Kyoto Pharmaceutical University, Kyoto, 607-8414, Japan., Yamazaki CM, Nose H, Awada C, Takao T, Koide T

المصدر: Biopolymers [Biopolymers] 2013 Nov; Vol. 100 (6), pp. 705-13.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Wiley Country of Publication: United States NLM ID: 0372525 Publication Model: Print Cited Medium: Internet ISSN: 1097-0282 (Electronic) Linking ISSN: 00063525 NLM ISO Abbreviation: Biopolymers Subsets: MEDLINE

مواضيع طبية MeSH: Drug Carriers* , Peptides*/chemistry, Animals ; Collagen/chemistry ; Protein Conformation ; Protein Structure, Secondary

المؤلفون: Yamazaki CM; Department of Chemistry and Biochemistry, School of Advanced Science and Engineering, Waseda University, Shinjuku, Tokyo 169-8555, Japan., Nakase I, Endo H, Kishimoto S, Mashiyama Y, Masuda R, Futaki S, Koide T

المصدر: Angewandte Chemie (International ed. in English) [Angew Chem Int Ed Engl] 2013 May 17; Vol. 52 (21), pp. 5497-500. Date of Electronic Publication: 2013 Apr 16.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Wiley-VCH Country of Publication: Germany NLM ID: 0370543 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1521-3773 (Electronic) Linking ISSN: 14337851 NLM ISO Abbreviation: Angew Chem Int Ed Engl Subsets: MEDLINE

مواضيع طبية MeSH: Cell-Penetrating Peptides/*chemical synthesis , Collagen/*chemistry , Drug Carriers/*chemical synthesis, Amino Acid Sequence ; Cell-Penetrating Peptides/chemistry ; Drug Carriers/chemistry ; Endocytosis/drug effects ; Flow Cytometry ; HeLa Cells ; Humans ; Microscopy, Confocal ; Molecular Sequence Data ; Protein Conformation ; Protein Transport